Summary
A novel derivative of 4-H-quinolizine, 3-cyano-1ethoxycarbonyl-4-imino-2-isopropyl-4-H-quinolizine (KAV-397), was-discovered to inhibit replication of. human immunodeficiency virus type 1 (HIV-1) in T-Iymphocyte cell lines. HIV-infected T cells proliferated at the same growth rate as un infected cells for at least 8 days when the cells were co-cultivated with KAV-397, while infected control cells died in 3 or 4 days. This compound inhibited reverse transcriptase (RT) activity of HIV-1 but did not compete with either deoxythymidine triphosphate substrates nor template-primers. It had no or little effect on RT activities of HIV-2, avian leukosis virus (AlV) and murine leukaemia virus (MulV). Regarding eukaryotic DNA-dependent DNA polymerases, it significantly suppressed chicken DNA polymerase ex and slightly suppressed ' Y but not murine DNA polymerase [3.
Inhibition of replication of human immunodeficiency virus (HIV) as the causative agent of AIDS is one of the most important themes for the treatment of AIDS. Inhibitors of HIV reverse transcriptase (Rl) are potent and prospective agents of anti-HIV treatment because RT is thought to be one of the best targets for chemotherapy (DeClercq and Balzarini, 1985; Oberg, 1986) . We report here the inhibitory effects of a 4-H-quinolizine derivative (KAV-397) On HIV replication in T lymphocytes. We investigated its effects on RTfrom several retroviruses and DNA polymerases of mouse and chicken. Our analysis of its mode of action on RT of HIV-1 suggested a different mode of action from nucleoside analogues (competing with substrate Resubmission received 15 April, 1991; revised 18 April, 1991. 'For correspondence. Tel. (0263) 82-8820; Fax. (0263) 82-8826. nucleotide; St. Clair et al., 1987) and suramin (competing with template-primer; Ono et al., 1988) .
Effect of KAV-397 on HIV-1 replication in Tlymphocyte cell lines
The HTLV-I-carrying cell line, MT-2 (Miyoshi etal., 1982a) and MT-4 (Miyoshi et al., 1982b) cells and clone 8 of the leukaemic T-cell line MOLT-4 cells (Kikukawa et al., 1986) were used to estimate virus-induced cytopathic effects. HTLV-IIIB (Popovic et al., 1984) and LAV (Montagnier et al., 1984) for infected cell cultures were prepared from culture supernatant of persistently infected MOLT-4 cells. All cultures were performed in RPMI-1640 supplemented with 10% foetal calf serum and 50 fL9/ml kanamycin in 5% CO 2 at 3JCC. KAV-397 was prepared from ethyl 2-pyridylacetate and 2-cyano-3-ethoxy-3-isopropylacrylonitrile according to the method previously described by Kurata et al. (1975) . Dimethylsulphoxide (DMSO) for solvent was purchased from Wako Pure Chemical Industries Ltd (Osaka, Japan). 3 x 10 s cells of MT-4 or MT-2 cells were incubated for 1 h at 37°C with 100 TCID so of HIV-1 (HTLV-IIIB) and cultured in 24~well plates at 3JCC, 5% CO 2 . Control cells were treated similarly but were not exposed to the virus. A portion of cultured cells was withdrawn and numbers of viable cells were counted by the trypan blue dye exclusion method every 24 h from the third day after virus inoculation. Cultures were diluted five times on Days 3, 6 and 9. Infectious titres of HIV-1 in these culture supernatants were determined by using MT-4 cells. That is, culture supernatants were sequentially diluted with RPMI-1640 10 times and 2 x 10 4 MT-4 cells were cultured in 96-well plates for 7 days with the diluted supernatants. The cytopathic end-points were determined under the microscope and virus titres were calculated. KAV-397 was dissolved with 100% DMSO and diluted with culture medium. Final concentrations of DMSO in the cell cultures were less than 0.1%. Infectious tit res were checked as described above.
KAV-397 suppressed HIV-induced cytopathic effects in a dose-dependent manner (Fig. 1 ). HIV-infected MT-4 cells were completely stained with trypan blue 3 or 4 days Effect of KAV-397 on virus production in persistently infected MOLT-4 cells These results indicate that KAV-397 had a suppressive effect on HIV-1 replication in T-lymphocyte cell lines. In our cell culture system using MT-4 cell lines, cell growth is faster than previously reported (e.g. Mitsuya et a/., 1988) and infected cells cultured with KAV-397 grew by about 100 times for 10 days with three subcultures. This high growth rate of infected cells without virus replication indicated a reliable efficacy of KAV-397 as an anti-HIV agent.
MOLT-4 cells persistently infected with HIV-1HTLV-IIiB cells were co-cultured for 4 days in the presence of KAV-397 and virus titres were checked as described above. It was demonstrated that KAV-397 had no significant suppression of virus replication in chronically infected cells. Namely, when persistently infected MOLT-4 cells were cultured in the presence of 0,17.7,35.3 and 70.7J.LM of KAV-397, TCID 501ml of culture supernatants were 10 5 . 9 5 , 10 5 . 05 , 10 5 . 16 and 10 5 . 05 . Similar results were obtained in the presence of 1 J.Lg/ml of AZT (10 6 . 1 Oj.
Inhibitory effect of KAV-397 on RT and DNA polymerases Preparations of RT of HIV-1, HIV-2 and Moloney murine leukaemia virus for testing any suppressive effects of KAV-397 were conducted as follows. Briefly, 1 ml of culture supernatants of persistently infected cell lines was centrifuged at 17000 9 tor 90 min at 4°C in a microcentrifuge (Hitachi, Tokyo, Japan). Supernatants were discarded and then pelleted virus particles were disrupted by adding Tris-buffered saline (pH 7.85) containing 1 mM EDTA, 100mM NaCI and 2% Triton X-100. This preparation was performed immediately before use. HIV-2 GH -1 was kindly supplied by Dr Ishikawa, National Institute of Health (Tokyo, Japan) (Ishikawa et a/., 1988) . 2K1Mo cells persistently infected with Moloney murine leukaemia virus were kindly supplied by Dr Hoshino, Gunma University, Gunma, Japan. Avian leukosis virus RT was purchased from Sigma. Reverse transcriptase activity was measured with poly(rA)dT 12 -18 as the template-primer under the optimal conditions described below. Briefly, the reaction mixture for HIV RT contained (50J.L1 final volume) 50mM Tris~HCI (pH 7.85), 50mM KCI, 10mM MgCI2, 5mM dithiothreitol, 25J.Lg/ml poly(rA)dT 12 _ 18 and 10J.LM [3H] dTTP.The reaction mixture for MuLV RTactivity contained 1 mMMgCI 2 instead of 10 mMMgCI 2 • In the case of ALV RT activity, the reaction mixture contained 50mM Tris-HCI (pH 8.3) and 6 mM MgCb instead of 50 mM Tris-HCI (pH 7.85) and 10mM MgCI 2 • Reactions were carried out in a water bath at 37°C for 60 min. Each reaction fluid was spotted onto a DE81 filter paper disc and processed for measurement of radioactivity as described previously (Lindel et a/., 1967) . Incorporation of [3H]dTTP increased linearly under these reaction conditions for 120 min. Dithiothreitol and poly(rA)dT 12 -18 were obtained from Sigma (St Louis, MO). [3H]-2",3'-dideoxythymidine was purchased from Amersham (Uppsala, Sweden).
For DNA polymerases and their enzyme assay, recombinant murine DNA polymerase f3 expressed in Escherichia coli (Date et a/., 1988) and chicken DNA polymerase ex and 0 (yamaguchi et al., 1980, 1982) purified from chick embryo were kindly supplied from Dr Matsukage (Aichi Cancer Center Research Institute, Aichi, Japan). Enzymes were stored at -20°C in 50mM Tris-HCI buffer, pH 7.8, containing 1mM EDTA, 1mM dithiothreitol and 50% glycerol. Assays were performed following the protocol described previously (Date et al., 1988; Yamaguchi et al., 1980 Yamaguchi et al., , 1982 with the same scale of volume as in the RT assay. KAV-397 suppressed RT activity of HIV-1 LAV in a dose-dependent manner from a concentration of 7.1 fLM ( Fig.2a ).With 70 fLM of KAV-397, 50% inhibition of enzyme activity was observed. On the other hand, KAV-397 inhibited DNA polymerase IX by 45% at a concentration of 80 fLM. This suppressive effect was the same or less than the effect on RT of HIV-1. DNA polymerase [3 was not inhibited by KAV-397 at all concentrations tested and DNA polymerase ' Y was suppressed slightly (15% inhibition) at a concentration of 80 fLM of KAV-397 ( Fig. 2a ). KAV-397 could not attain complete inhibition of these polymerases. Its suppressive effects reached a plateau above 80 fLM, presumably owing to its limit of solubility.
KAV-397 showed no or little inhibition of RT from HIV-2, Molony MuLV and avian leukosis virus (Fig. 2a) . But it is feasible that the effect of KAV-397 on RT from other viruses was so weak that we could not detect it. We further tested for suppressive effect of KAV-397 on Moloney murine leukaemia virus replication in 3T3S+Lcells and it showed no effect on the replication of this virus (data not shown).
Analysis of inhibition of HIV-1 reverse transcriptase
HIV-1 LAV particles were purified through a sucrose gradient (20-60%) by ultracentrifuge and RT enzyme prepared for detailed analysis of inhibition by KAV-397. RTreactions were performed as described above but using a RT preparation from purified HIV-1 LAV particles. Enzyme solution and substrates buffer in equal volume were prepared on ice supplemented with an equal concentration of KAV-397. The reaction was started by mixing both components. After incubation for 15, 30, 45, 60 minutes at 37°C in a water bath, the reaction mixture was sampled and spotted onto a DEAEfilter and radioactivity measured as described above. Reaction rates were calculated from four reaction samples of different reaction times and averaged. A Hofstee plot was used for the analyses.
Inhibition of RT activity of HIV-1 by KAV-397 was analysed kinetically by changing the concentration of either the template-primer or the substrate deoxythymidine triphosphate. Analyses of enzyme inhibition were carried out under conditions of 0 and 20 fLM of KAV-397 and the results are shown in Fig. 2b,c . The mechanism of inhibition by KAV-397 was revealed to be non-competitive to deoxythymidine triphosphate (Fig. 2b) . The inhibition constant (Iq was calculated to be 64.5 fLM using data with 20fLM of KAV-397. Also in Fig. 2c , it can be seen that inhibition by KAV-397 was not competitive with templateprimers. We deduced that KAV-397 suppressed RT activity of HIV-1 by recognizing an irrelevant moiety of RT from binding with substrates or template-primers.
The inhibitory effects of KAV-397 on RT activities were more specific than previously reported using suramin sodium, which was demonstrated to inhibit RT activity by competing with template-primers (Ono et al., 1988) . The profile of inhibition of DNA polymerase is similar with suramin sodium in that it suppressed DNA polymerase IX significantly and DNA polymerase ' Y slightly. It is worth noticing that DNA polymerase IX was not suppressed any more than RT from HIV-1 by KAV-397, while it was suppressed more severely than RT of ALV by suramin sodium. These types of RT inhibitors have a different mode of action from nucleoside analogues represented by 3'-azido-3' -deoxythymidine (AZT) (Vrang et al., 1987) . In order to suppress RT activity completely in vivo, development of several inhibitors with different modes of action on RT will be necessary because the appearance of resistant virus against AZT has been reported recently (Mitsuya et al., 1990) . From this point of view, KAV-397 has the possibility of being one of a new type of HIV suppression agent, in spite of its lower selectivity index compared to nucleotide or nucleoside analogues. The K; value of KAV-397 on RT of HIV-1 was rather high.
So, we cannot exclude the possibility that KAV-397 may have an alternative pathway to inhibit virus replication. But its suppressive effect must be in the process before integration of virus gene into host cell genome because it had no effects on virus replication in persistently infected MOLT-4 cells. In conclusion we consider that KAV-397 is an interesting compound and has the possibility of being a progenitor compound of a subsequent series of novel anti-HIVagents.
